Taking Sandoz out of estimates, the brokerage now expects consolidated revenue growth in mid-single digit for Aurobindo over the next two y...

Brokerages see the termination of the deal as a setback to scale up sales in the US .

The transaction if completed would have positioned the Hyderabad-based firm as the second largest dermatology player and the second largest...

In September last year, the USD three billion drug maker said its US subsidiary entered into an agreement to acquire commercial operations ...

Aurobindo Pharma Ltd. to invest $ 200 million on Capex and over 5% of sale value on R&D.

The acquisition will add approximately 300 products including projects in development as well as commercial and manufacturing capabilities ...

US drug firm Sandoz Inc is recalling over 2,70,000 bottles of hypertension tablets, manufactured by Hyderabad-based Mylan Laboratories.

According to a statement by the drug maker, Aloxi is currently distributed by Helsinn Healthcare's marketing partner, Eisai Inc in the USA.

Drug firm Sandoz Inc is recalling India-made 1,023,430 units of anti-allergic Cetirizine HCl chewable tablets in the US due to impurity con...

The Israeli drug maker already is involved in various legal battles with other drug firms over the patent litigations of Copaxone.

The decision by the Supreme Court comes at a time when Teva is switching its daily version of Copaxone to twice a week version.

UCB alongwith others has filed separate cases against as many as 15 drug makers for allegedly infringing its patented drug Vimpat.

Indian drug makers are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and ...

Natco Pharma has lost a patent litigation against Israel's Teva Pharmaceutical Industries in the US over multiple sclerosis treatment drug,...

Drug company Aurobindo Pharma today said it has received final approval from the US Food and Drug Administration (US FDA) to sell anti-biot...

NYSE listed Dr Reddy’s Laboratories (DRL), India’s second largest company by revenue, is embroiled in a fresh patent infringement row with ...

A tax tribunal today said overseas firms providing research facilities for clinical and bio-analytical studies to Indian companies for deve...